Social Corporation Keigakukai Minamiosaka Hospital
Osaka, Japan
General hospital in Osaka
1 Chome-18-18 Higashikagaya, Suminoe Ward, Osaka, 559-0012
About Social Corporation Keigakukai Minamiosaka Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
3
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
2
Clinical Trials at Social Corporation Keigakukai Minamiosaka Hospital
During the past decade, Social Corporation Keigakukai Minamiosaka Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
2,025
Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
1,111
A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects
2017-12-12
2019-10-11
Completed
162
A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects
2017-12-13
2019-11-28
Completed
164
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Social Corporation Keigakukai Minamiosaka Hospital"
#1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Social Corporation Keigakukai Minamiosaka Hospital
According to Clinical.Site data, the most researched conditions in "Social Corporation Keigakukai Minamiosaka Hospital" are
"Anemia" (2 trials), "Colorectal Cancer" (2 trials), "Renal Insufficiency, Chronic" (2 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Social Corporation Keigakukai Minamiosaka Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Social Corporation Keigakukai Minamiosaka Hospital
Most popular intervention types in "Social Corporation Keigakukai Minamiosaka Hospital" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Darbepoetin alfa" (2 trials), "Molidustat (BAY85-3934)" (2 trials), "UFT adjuvant chemotherapy" (2 trials), "Finerenone (BAY94-8862)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Social Corporation Keigakukai Minamiosaka Hospital
The vast majority of trials in "Social Corporation Keigakukai Minamiosaka Hospital" are
5 trials for "All" genders.
Clinical Trials Status at Social Corporation Keigakukai Minamiosaka Hospital
Currently, there are NaN active trials in "Social Corporation Keigakukai Minamiosaka Hospital".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Social Corporation Keigakukai Minamiosaka Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Social Corporation Keigakukai Minamiosaka Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".